JOURNAL OF CLINICAL NEUROSCIENCE is an esteemed publication dedicated to advancing the field of neurology and related medical disciplines. Published by ELSEVIER SCI LTD, this journal serves as a vital resource for researchers, clinicians, and educators, providing a platform for the dissemination of high-quality research findings since its inception in 1994. With a noteworthy impact factor and ranked within the Q2 and Q3 categories across various medical specialties, including neurology and surgery, the journal positions itself at the forefront of clinical neuroscience. Although it operates under a traditional subscription model, the journal’s commitment to publishing rigorous scientific work ensures that it remains an integral reference for anyone involved in the diagnosis, treatment, and understanding of neurological disorders. Readers can access a diverse array of articles that not only highlight current research trends but also foster the exchange of innovative ideas in clinical practice.

Current Neurology and Neuroscience Reports, published by Springer, is a leading peer-reviewed journal dedicated to advancing the field of neurology and neuroscience. With a notable impact factor and a reputable standing in the academic community, as evidenced by its Q1 rankings in both Neurology (Clinical) and Neuroscience (Miscellaneous) for 2023, this journal is ranked #49 out of 400 in clinical neurology and #21 out of 113 in general neuroscience, placing it in the 87th and 81st percentiles respectively.

Since its inception in 2001, it has provided a platform for groundbreaking research, comprehensive reviews, and critical insights into contemporary issues affecting the nervous system. Aimed at researchers, clinicians, and students alike, Current Neurology and Neuroscience Reports fosters interdisciplinary dialogue and knowledge exchange, addressing a broad spectrum of topics from clinical neurology to theoretical neuroscience. By publishing high-quality research, the journal not only contributes to the scientific community but also aims to enhance patient care and inform clinical practices. As a vital resource in neurological research, it invites contributions from a diverse range of studies to expand understanding in this ever-evolving field.

ACTA NEUROLOGICA BELGICA is a leading academic journal published by Springer Heidelberg, dedicated to advancing the field of neurology and medicine. With an ISSN of 0300-9009 and E-ISSN 2240-2993, this journal has been a vital resource since its inception, contributing significantly to neurological research and clinical practice. It holds a respectable impact factor with categories spanning from Q2 in Medicine (miscellaneous) to Q3 in Neurology (clinical) as of 2023, indicating its prominence in the scientific community. The journal's extensive coverage since 1959 enhances its historical relevance, while its ongoing publication until 2024 ensures the latest developments are readily accessible. Researchers and practitioners can benefit from its rigorous peer-reviewed articles, which are crucial for staying current in this rapidly evolving discipline. As a scholarly platform, ACTA NEUROLOGICA BELGICA plays a pivotal role in disseminating knowledge and fostering innovation in neurology, making it a must-read for professionals, students, and anyone involved in the field.

Future Neurology, published by Future Medicine Ltd, is an emerging peer-reviewed journal dedicated to the rapidly evolving field of neurology, with a keen focus on both clinical and translational research. Since its inception in 2007, the journal has provided a unique platform for sharing innovative findings and fostering collaboration among neurologists, neuroscientists, and healthcare professionals. Although currently categorized in the Q4 quartile for both Neurology and Clinical Neurology, Future Neurology strives to improve its impact factor by publishing high-quality research and reviews that address pressing issues in neurological health. With its commitment to disseminating knowledge, the journal serves as an essential resource for professionals and researchers seeking to stay informed about advancements in neurological science. It is particularly valuable for those looking to contribute to and engage with the latest developments in neurotherapeutics, diagnostics, and patient care strategies. The journal is indexed in major databases and is available in print and online formats, ensuring wider accessibility to its content for all stakeholders in the field.

JOURNAL OF THE NEUROLOGICAL SCIENCES, published by Elsevier, is a leading academic journal that has been at the forefront of neurology research since its inception in 1964. With a robust scope covering both clinical and experimental neurological sciences, this journal serves as an invaluable resource for researchers, practitioners, and students in the field. The journal is indexed with an impressive Q2 ranking in Neurology and a remarkable Q1 status in Clinical Neurology as of 2023, reflecting its high impact and relevance in the medical community. The journal's Scopus rankings further emphasize its significance, holding the 69th position in clinical neurology and 35th in neuroscience, marking it in the top 82nd percentile of its peers. While the journal operates under a traditional subscription model, it continues to offer a platform for groundbreaking research and comprehensive reviews that advance our understanding of neurological disorders. Researchers and clinicians alike will find the JOURNAL OF THE NEUROLOGICAL SCIENCES an essential contribution to the literature, paving the way for innovations in clinical practices and therapeutic strategies.

Progress in Neurology and Psychiatry is a pivotal journal published by John Wiley & Sons Ltd, dedicated to advancing the fields of neurology and psychiatry. With a robust history dating back to its establishment, this esteemed journal holds a consistent Q3 ranking in 2023 across several categories including Neurology, Clinical Neurology, Psychiatry, and Mental Health, signifying its significant contribution to the scientific community. This journal serves as a vital source of knowledge and insight, publishing original research, reviews, and case studies that explore the intricacies of neurological and psychiatric disorders. Although it does not offer open access, the journal remains accessible to a wide audience through institutional subscriptions. By fostering a platform for scholarly discourse, Progress in Neurology and Psychiatry aims to bridge the gap between research and practice, ultimately enhancing the quality of care for individuals with neurological and psychiatric conditions. Researchers, clinicians, and students are encouraged to engage with the journal's comprehensive content to stay informed of the latest developments and emerging trends in these critical fields of medicine.

Neurology Asia is a prestigious peer-reviewed journal dedicated to advancing the field of neurology in the Asia-Pacific region. Published by the ASEAN NEUROLOGICAL ASSOCIATION, this journal serves as a vital platform for sharing innovative research and clinical practices among neurologists and neuroscientists. With an ISSN of 1823-6138, it encompasses a broad range of topics within the realm of neurology and clinical neurology, allowing for an expansive dialogue on neurological disorders, treatments, and advancements in medical science. Although currently positioned in the Q4 quartile of both neurology and clinical neurology categories, it is committed to enhancing its reputation and impact within the academic community. While the journal is not an open-access publication, it strives to provide authors a respectable outlet for disseminating critical research findings. The journal’s address, located at the UNIV MALAYA MEDICAL CENTRE in Kuala Lumpur, Malaysia, reflects its commitment to fostering regional advancements in neurological research. By engaging with Neurology Asia, researchers, professionals, and students will contribute to shaping the future of neurology across Asia.

NERVENARZT, published by Springer, has established itself as a significant platform in the fields of Medicine, Neurology, and Psychiatry since its inception in 1947. With a focus on a wide array of topics in neurological and psychiatric health, the journal plays a crucial role in disseminating cutting-edge research and clinical insights that enhance understanding and treatment of neurological disorders. The journal is currently positioned in the Q3 category across various fields, reflecting its role in the academic community, and provides valuable contributions to both the clinical and theoretical aspects of neurology and psychiatry. While it does not offer open access options, NERVENARZT continues to make significant strides in literature with its comprehensive articles and research findings, aimed at researchers, healthcare professionals, and students interested in the latest developments in the neuroscience and mental health landscapes. Operating under rigorous academic standards, it holds respected rankings with Scopus, further underscoring its commitment to impactful scholarship through the years.

Annals of Clinical and Translational Neurology is a premier journal published by WILEY, focusing on the fields of neurology and neuroscience. Since its inception in 2014, it has established itself as an Open Access platform, providing unrestricted access to cutting-edge research to promote scientific collaboration and innovation. With an impressive Impact Factor residing in the top quartile (Q1) for both clinical neurology and miscellaneous neuroscience in 2023, this journal ranks #52 out of 400 in the Neurology category and #22 out of 113 in General Neuroscience, indicating its significant contribution to the field. The journal welcomes submissions that address emerging trends and challenges in translational neurology, aiming to bridge the gap between laboratory research and clinical practice. By disseminating high-quality research and fostering a community of scholars, Annals of Clinical and Translational Neurology plays a vital role in advancing our understanding of neurological disorders and improving patient care worldwide.

CLINICAL NEUROLOGY AND NEUROSURGERY, published by Elsevier, is a pivotal journal in the fields of neurology and neurosurgery, recognized for its rigorous peer-review process and commitment to advancing clinical practices. Established in 1974, the journal has become a respected source of innovative research, evidenced by its excellent Scopus rankings—placing it within the top half of journals in both Medicine (Surgery) and the clinical aspect of Neurology. Notably, it has achieved a Q2 ranking in both Medicine (miscellaneous) and Surgery, and Q3 in Neurology (clinical) as of 2023. The journal publishes a wide array of articles focused on the latest findings, clinical practices, and technological advancements that address neurological disorders and surgical interventions. While it does not currently operate under an open-access model, it remains highly accessible to academic institutions and professionals worldwide from its editorial base in the Netherlands. By enabling knowledge-sharing and fostering collaboration among researchers, practitioners, and students, CLINICAL NEUROLOGY AND NEUROSURGERY plays a crucial role in shaping the future of clinical neurology and surgical techniques.